A simple, accurate and reproducible reversed-phase liquid chromatographic method was developed for qualitative and quantitative determination of four bioactive flavonoids (ampelopsin, taxifolin, myricetin and quercetin) from the fruit-stalk extract of Hovenia dulcis Thunb. Chromatographic separation was performed on a C18 column (4.6 × 150 mm, 3.5 µm) with mobile phase consisting of 0.1% acetic acid and 100% acetonitrile at a flow rate of 1.0 mL/min. The analysis was performed using a diode array detector at 365 nm. The method was validated in terms of selectivity, linearity, accuracy, precision and recovery. Good linearity was observed over the investigated concentration range (10–500 μg/mL), with correlation coefficient values greater than 0.99. The intra- and inter-day precisions over the concentration range were <3.91% (relative standard deviation), and the accuracy was between 91.57 and 106.66%. The mean recovery for all the analytes was 100.87%. This method was successfully applied in the quality assessment of bioactive flavonoids in the fruit-stalk extract of H. dulcis.

Introduction

Hovenia dulcis Thunberg (Rhamnaceae), known as Oriental Raisin tree, is indigenous to Korea, China and Japan. Parts of the tree, namely the seeds, fruit stalk, leaves and stem bark, are commonly used as folk remedies in oriental medicine (1). The fruit stalk of H. dulcis, also called ‘Jiguja’ in Korean, is of special interest; it is reported to have detoxification effects on alcohol poisoning, and hepatoprotective, antioxidant, antidiabetic, antiobesity, antiallergic and anticancer activities (210). Because of these health benefits, it has been widely used as an ingredient in natural health products and functional foods in East Asia (1, 3). In addition, there have been many industrial attempts to produce dietary supplements and functional food products using the fruit-stalk extracts (11). For example, a beverage containing H. dulcis fruit-stalk extract (HFE) has been reported to be effective in relieving ethanol-induced hangover in rats (12). Another study showed that the soy sauce containing HFE exhibited higher antioxidant activity and alcohol dehydrogenase activity than normal soy sauces (13).

A quality assessment of dietary supplements or functional foods is critical to ensure their expected performance. As part of the quality assessment, the principal bioactive constituents or markers should be established and monitored. Phenolic compounds and triterpene saponins have been identified in HFE as the bioactive constituents responsible for the demonstrated health effects. The phenolic compounds reported are hovenodulinol, hovenitins I, II and III, (+)-3,3′,5′,5,7-pentahydroflavanone, laricitrin, myricetin, (+)-gallocatechin, dihydrokaempferol, dihydromyricetin (ampelopsin) and quercetin; the triterpene saponins reported are saponin C2, β-daucosterol, hovenidulciosides A1, A2, B1 and B2, hodulosides I and III and hovenidulcigenin (8, 9, 1417). As such, the chemical components of HFE have been extensively investigated; however, to the best of our knowledge, qualitative or quantitative analytical methods for HFE have not yet been reported and the information on the content of its bioactive constituents is not available.

To establish the marker bioactive compounds of H. dulcis fruit, the extracts were preliminarily analyzed using high-performance liquid chromatography (HPLC). Four major chromatographic peaks were detected, attributed to ampelopsin, taxifolin, myricetin and quercetin, which have all been reported as major constituents of H. dulcis (14, 15, 18). Ampelopsin, also known as dihydromyricetin, possesses hepatoprotective activity, inhibits alcohol-induced muscular relaxation and counteracts alcohol intoxication and dependence (1921). Taxifolin exhibits antioxidant activity and potential chemopreventive effects by regulating genes via an antioxidant response element-dependent mechanism (22). Myricetin exhibits antiallergic, antioxidant and hypoglycemic effects in diabetic rats (2325). Quercetin enhances 5-fluorouracil efficiency in cancer treatment and reduces high-fat-diet-induced fat accumulation in mice (26, 27). HPLC analytical methods for each of these four flavonoids have been reported (2831), but the method for simultaneous detection of these all compounds has not yet been published. Therefore, we selected these four flavonoids as bioactive marker compounds of HFE and developed an HPLC method for the quantitative determination of these four flavonoids. This article presents a simple, accurate, reproducible and thoroughly validated HPLC-based method for qualitative and quantitative analysis of these four flavonoids, as part of the quality assessment of products containing HFE.

Experimental

Chemicals and reagents

Ampelopsin (purity >98%), taxifolin (purity >85%), myricetin (purity >96%) and quercetin (purity >98%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). HFE samples were provided by Lifetree Biotech Co., Ltd. (Suwon, Korea). All other solvents used were of HPLC grade and purchased from J. T. Baker (Phillipsburg, NJ). Distilled water was prepared using a Milli-Q purification system (Millipore, Billerica, MA).

Preparation of HFE samples

The HFE samples were prepared by Lifetree Biotech Co., Ltd. using the following procedure. The powder of dried fruits of H. dulcis (25 g) was extracted with water (1 L) at 100°C for 3 h, and the extract solution was centrifuged for 10 min at 4,000 rpm to remove insoluble particles. The solution was then freeze-dried for 24 h.

Standard solutions and sample preparation

Standard stock solutions of ampelopsin, taxifolin, myricetin and quercetin were prepared at a concentration of 2 mg/mL in 80% methanol. The standard solutions were serially diluted with 80% methanol to obtain calibration standard solutions at concentrations of 10, 20, 50, 100, 200 and 500 µg/mL for all the analytes. Quality control (QC) samples were prepared at 20, 100 and 500 µg/mL in the same manner as the calibration standard solutions.

HFE samples were dissolved in 80% methanol at a concentration of 250 mg/mL and were centrifuged at 13,200 rpm for 5 min. The supernatant was collected and filtered through a 0.45-μm polytetrafluoroethylene (PTFE) syringe filter (Whatman International Ltd., Maidstone, England).

HPLC condition

Agilent 1260 infinity HPLC system, equipped with a photo diode array detector (Agilent Technologies, Palo Alto, CA), was used for the analysis. The chromatographic separation was achieved using an Xbridge™ Shield RP18 column (4.6 mm I.D. × 150 mm, 3.5 µm) (Waters, Milford, USA), with column oven temperature maintained at 20°C. The mobile phase consisted of 0.1% acetic acid (Solvent A) and 100% acetonitrile (Solvent B). The mobile phase flow rate was 1.0 mL/min with gradient elution. The percentage composition of Solvent B was maintained at 20% for 3 min, gradually increased to 38% for 24 min, further increased to 90% for 1 min and maintained at 90% for 5 min, which was followed by equilibration to the initial composition for 6 min. The injection volume was 10 µL, and UV absorbance was monitored at 365 nm.

Method validation

The validation of the analytical method was performed according to our routine validation protocol, and the details are as follows. The specificity of the developed method was examined by comparing the chromatographic profile of the reference standards with that of HFE samples, in terms of retention time, pattern of the UV spectrum and maximum absorption wavelength (λmax). Linearity was evaluated using the linear correlation coefficient (r2) of the calibration curve for each analyte. The limit of detection (LOD) and the limit of quantitation (LOQ) were determined based on the lowest detectable peak in the chromatogram, with a signal-to-noise (S/N) ratio of 3 and 10, respectively. Precision was evaluated by replicate analyses of QC samples at low, medium and high concentrations (20, 100 and 500 µg/mL, respectively) and expressed as percent relative standard deviation (% RSD). Accuracy was assessed by comparing nominal versus measured concentrations of the QC samples and expressed as a percentage of the nominal concentration. Intra-day precision and accuracy were determined from the variability of the replicate analyses (n = 5) in the same analytical run. The inter-day assay was examined for three consecutive days. Recovery was determined by calculating the percent recovery of the standard-fortified samples at two concentrations (n = 3).

Results

Chromatography

When an HFE sample was preliminarily analyzed using HPLC, four major peaks were detected in the chromatogram, which were attributed to ampelopsin, taxifolin, myricetin and quercetin (Figure 1) by comparison with literature data and their corresponding reference standards. Accordingly, these flavonoids were selected as the markers for HFE, and the HPLC conditions were optimized for these compounds. A typical chromatogram of a HFE sample is shown in Figure 2. Ampelopsin, taxifolin, myricetin and quercetin were eluted at retention times of 6.2, 10.8, 18.1 and 26.1 min, respectively. All compounds were completely separated within 30 min. The UV absorption spectra (200–400 nm) of the standard compounds are shown in Figure 1. Although the UV absorption maximum of each compound was different, the monitoring wavelength was selected as 365 nm. All analytes showed satisfactory absorbance at this wavelength, and all peaks were well resolved with baseline separation.
Figure 1.

Chemical structures and UV spectra of four bioactive flavonoids from H. dulcis fruit extracts.

Figure 2.

Representative HPLC chromatograms of the standard mixture (A) and H. dulcis fruit extracts (B). 1, Ampelopsin; 2, taxifolin; 3, myricetin; and 4, quercetin.

Analytical method validation

The selectivity of the method was determined by comparing certain parameters of the chromatographic profile, such as retention time, structure of the UV spectrum and λmax of the reference standards and the HFE sample. Chromatographic profiles of the standard mixture and the HFE sample were identical with regard to the parameters mentioned above (Figure 2). In addition, no interference was observed at the retention times of any analytes in the chromatogram of the extract.

The calibration curves for ampelopsin, taxifolin, myricetin and quercetin were made by plotting the peak area versus the concentration for each analyte using least-square regression analysis. Each calibration curve was obtained using six levels of concentrations in the range 10–500 µg/mL, in triplicate. The ranges of all the calibration curves were adequate for simultaneous analysis of the four flavonoids in the HFE samples. The linear correlation coefficient (r2) for all calibration curves was higher than 0.999 for all analytes, indicating good linearity over the investigated range (Table I).

Table I.

Calibration Curve Data for Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteCalibration curveR2Linear range (µg/mL)LOD (µg/mL)LOQ (µg/mL)
Ampelopsiny = 2.07964x +4.946880.99910–5000.52.0
Taxifoliny = 2.06722x +10.268860.99910–5000.51.0
Myricetiny = 22.43971x –237.693230.99910–5000.20.5
Quercetiny = 25.70407x –171.980220.99910–5000.10.3
AnalyteCalibration curveR2Linear range (µg/mL)LOD (µg/mL)LOQ (µg/mL)
Ampelopsiny = 2.07964x +4.946880.99910–5000.52.0
Taxifoliny = 2.06722x +10.268860.99910–5000.51.0
Myricetiny = 22.43971x –237.693230.99910–5000.20.5
Quercetiny = 25.70407x –171.980220.99910–5000.10.3
Table I.

Calibration Curve Data for Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteCalibration curveR2Linear range (µg/mL)LOD (µg/mL)LOQ (µg/mL)
Ampelopsiny = 2.07964x +4.946880.99910–5000.52.0
Taxifoliny = 2.06722x +10.268860.99910–5000.51.0
Myricetiny = 22.43971x –237.693230.99910–5000.20.5
Quercetiny = 25.70407x –171.980220.99910–5000.10.3
AnalyteCalibration curveR2Linear range (µg/mL)LOD (µg/mL)LOQ (µg/mL)
Ampelopsiny = 2.07964x +4.946880.99910–5000.52.0
Taxifoliny = 2.06722x +10.268860.99910–5000.51.0
Myricetiny = 22.43971x –237.693230.99910–5000.20.5
Quercetiny = 25.70407x –171.980220.99910–5000.10.3

The LOD and LOQ of the analytes were measured by analyses of serially diluted standard solutions. The LOD and LOQ for ampelopsin, taxifolin, myricetin and quercetin were in the ranges of 0.1–0.5 and 0.5–2.0 µg/mL, respectively. This indicates that this method can be used to detect trace amounts of these flavonoids and quantify them in crude extracts of H. dulcis fruits or in functional foods and dietary products containing the extract.

Intra-assay precision and accuracy were assessed by analyzing five sets of QC samples, independently prepared at low, middle and high concentrations. Inter-assay precision and accuracy were tested over 3 days, with the QC samples prepared each day. The RSD values of both intra-assay and inter-assay precision were below 3.91%, and the accuracy remained between 91.57 and 106.66%. The resulting precision and accuracy data were satisfactory for the quantitative analysis of the flavonoids in H. dulcis fruit extracts (Table II).

Table II.

Intra- and Inter-day Precision and Accuracy for Determination of Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteNominal concentration (µg/mL)Intra-day (n = 5)
Inter-day (n = 3)
Observed concentration (n = 5)
Mean ± SD
Accuracy (%)Precision (%)Observed concentration (n = 3)
Mean ± SD
Accuracy (%)Precision (%)
Ampelopsin2020.01 ± 0.39100.061.9620.01 ± 0.54100.042.69
100100.49 ± 0.63100.490.62100.42 ± 0.51100.420.51
500493.86 ± 3.498.770.69494.25 ± 2.3998.850.48
Taxifolin2018.56 ± 0.0892.780.4518.31 ± 0.2791.571.45
10099.65 ± 1.0499.651.04102.55 ± 2.09102.552.03
500496.61 ± 2.1199.320.42503.48 ± 3.68100.700.73
Myricetin2020.31 ± 0.12101.530.5920.45 ± 0.06102.230.27
10097.74 ± 3.8297.743.9195.84 ± 3.0795.843.20
500533.30 ± 3.93106.660.74527.06 ± 7.10105.411.35
Quercetin2020.64 ± 0.09103.220.4320.70 ± 0.02103.510.08
10094.92 ± 1.4994.921.5793.25 ± 1.7993.251.91
500503.88 ± 1.81100.780.36501.69 ± 3.12100.340.62
AnalyteNominal concentration (µg/mL)Intra-day (n = 5)
Inter-day (n = 3)
Observed concentration (n = 5)
Mean ± SD
Accuracy (%)Precision (%)Observed concentration (n = 3)
Mean ± SD
Accuracy (%)Precision (%)
Ampelopsin2020.01 ± 0.39100.061.9620.01 ± 0.54100.042.69
100100.49 ± 0.63100.490.62100.42 ± 0.51100.420.51
500493.86 ± 3.498.770.69494.25 ± 2.3998.850.48
Taxifolin2018.56 ± 0.0892.780.4518.31 ± 0.2791.571.45
10099.65 ± 1.0499.651.04102.55 ± 2.09102.552.03
500496.61 ± 2.1199.320.42503.48 ± 3.68100.700.73
Myricetin2020.31 ± 0.12101.530.5920.45 ± 0.06102.230.27
10097.74 ± 3.8297.743.9195.84 ± 3.0795.843.20
500533.30 ± 3.93106.660.74527.06 ± 7.10105.411.35
Quercetin2020.64 ± 0.09103.220.4320.70 ± 0.02103.510.08
10094.92 ± 1.4994.921.5793.25 ± 1.7993.251.91
500503.88 ± 1.81100.780.36501.69 ± 3.12100.340.62
Table II.

Intra- and Inter-day Precision and Accuracy for Determination of Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteNominal concentration (µg/mL)Intra-day (n = 5)
Inter-day (n = 3)
Observed concentration (n = 5)
Mean ± SD
Accuracy (%)Precision (%)Observed concentration (n = 3)
Mean ± SD
Accuracy (%)Precision (%)
Ampelopsin2020.01 ± 0.39100.061.9620.01 ± 0.54100.042.69
100100.49 ± 0.63100.490.62100.42 ± 0.51100.420.51
500493.86 ± 3.498.770.69494.25 ± 2.3998.850.48
Taxifolin2018.56 ± 0.0892.780.4518.31 ± 0.2791.571.45
10099.65 ± 1.0499.651.04102.55 ± 2.09102.552.03
500496.61 ± 2.1199.320.42503.48 ± 3.68100.700.73
Myricetin2020.31 ± 0.12101.530.5920.45 ± 0.06102.230.27
10097.74 ± 3.8297.743.9195.84 ± 3.0795.843.20
500533.30 ± 3.93106.660.74527.06 ± 7.10105.411.35
Quercetin2020.64 ± 0.09103.220.4320.70 ± 0.02103.510.08
10094.92 ± 1.4994.921.5793.25 ± 1.7993.251.91
500503.88 ± 1.81100.780.36501.69 ± 3.12100.340.62
AnalyteNominal concentration (µg/mL)Intra-day (n = 5)
Inter-day (n = 3)
Observed concentration (n = 5)
Mean ± SD
Accuracy (%)Precision (%)Observed concentration (n = 3)
Mean ± SD
Accuracy (%)Precision (%)
Ampelopsin2020.01 ± 0.39100.061.9620.01 ± 0.54100.042.69
100100.49 ± 0.63100.490.62100.42 ± 0.51100.420.51
500493.86 ± 3.498.770.69494.25 ± 2.3998.850.48
Taxifolin2018.56 ± 0.0892.780.4518.31 ± 0.2791.571.45
10099.65 ± 1.0499.651.04102.55 ± 2.09102.552.03
500496.61 ± 2.1199.320.42503.48 ± 3.68100.700.73
Myricetin2020.31 ± 0.12101.530.5920.45 ± 0.06102.230.27
10097.74 ± 3.8297.743.9195.84 ± 3.0795.843.20
500533.30 ± 3.93106.660.74527.06 ± 7.10105.411.35
Quercetin2020.64 ± 0.09103.220.4320.70 ± 0.02103.510.08
10094.92 ± 1.4994.921.5793.25 ± 1.7993.251.91
500503.88 ± 1.81100.780.36501.69 ± 3.12100.340.62

The recoveries were determined by a standard-fortified method at two concentrations. The average recoveries were 82.98–115.14% for all compounds with RSD values <2.83%. The results are summarized in Table III.

Table III.

Data for Recovery Studies of Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteFortified concentration (µg/mL)Observed concentration (µg/mL)Mean recovery (%, n = 3)RSD (%)
Ampelopsin5047.6695.322.63
250245.5698.220.94
Taxifolin5041.4982.982.83
250232.9593.180.86
Myricetin5057.57115.141.06
250273.45109.381.00
Quercetin5053.83107.671.03
250262.66105.060.86
AnalyteFortified concentration (µg/mL)Observed concentration (µg/mL)Mean recovery (%, n = 3)RSD (%)
Ampelopsin5047.6695.322.63
250245.5698.220.94
Taxifolin5041.4982.982.83
250232.9593.180.86
Myricetin5057.57115.141.06
250273.45109.381.00
Quercetin5053.83107.671.03
250262.66105.060.86
Table III.

Data for Recovery Studies of Ampelopsin, Taxifolin, Myricetin and Quercetin

AnalyteFortified concentration (µg/mL)Observed concentration (µg/mL)Mean recovery (%, n = 3)RSD (%)
Ampelopsin5047.6695.322.63
250245.5698.220.94
Taxifolin5041.4982.982.83
250232.9593.180.86
Myricetin5057.57115.141.06
250273.45109.381.00
Quercetin5053.83107.671.03
250262.66105.060.86
AnalyteFortified concentration (µg/mL)Observed concentration (µg/mL)Mean recovery (%, n = 3)RSD (%)
Ampelopsin5047.6695.322.63
250245.5698.220.94
Taxifolin5041.4982.982.83
250232.9593.180.86
Myricetin5057.57115.141.06
250273.45109.381.00
Quercetin5053.83107.671.03
250262.66105.060.86

Sample analysis

The developed analytical method was applied to simultaneous determination of the four flavonoids in the HFE samples. The concentrations of the flavonoids in different batches of HFE samples are presented in Table IV. The concentrations of ampelopsin, taxifolin, myricetin and quercetin were in the range of 0.88–1.19, 0.15–1.64, 0.04–0.24 and 0.03–0.13 mg/g of extract, respectively. The flavonoid content profiles were different among different batches of samples but generally, ampelopsin and taxifolin were the most abundant flavonoids. The variation in flavonoid contents was thought to be due to differences in origin, harvesting time and environmental conditions of raw plant materials, as well as differences in extraction recovery (3234).

Table IV.

Contents of Four Flavonoids in Hovenia dulcis Fruit Extract Samples

SampleContent (mg/g extract)
AmpelopsinTaxifolinMyricetinQuercetin
07030.88 ± 0.050.86 ± 0.050.17 ± 0.010.13 ± 0.01
07011.19 ± 0.030.15 ± 0.010.24 ± 0.010.03 ± 0.00
0807-51.17 ± 0.030.93 ± 0.020.06 ± 0.010.04 ± 0.01
0807-60.33 ± 0.071.64 ± 0.010.04 ± 0.010.05 ± 0.01
SampleContent (mg/g extract)
AmpelopsinTaxifolinMyricetinQuercetin
07030.88 ± 0.050.86 ± 0.050.17 ± 0.010.13 ± 0.01
07011.19 ± 0.030.15 ± 0.010.24 ± 0.010.03 ± 0.00
0807-51.17 ± 0.030.93 ± 0.020.06 ± 0.010.04 ± 0.01
0807-60.33 ± 0.071.64 ± 0.010.04 ± 0.010.05 ± 0.01
Table IV.

Contents of Four Flavonoids in Hovenia dulcis Fruit Extract Samples

SampleContent (mg/g extract)
AmpelopsinTaxifolinMyricetinQuercetin
07030.88 ± 0.050.86 ± 0.050.17 ± 0.010.13 ± 0.01
07011.19 ± 0.030.15 ± 0.010.24 ± 0.010.03 ± 0.00
0807-51.17 ± 0.030.93 ± 0.020.06 ± 0.010.04 ± 0.01
0807-60.33 ± 0.071.64 ± 0.010.04 ± 0.010.05 ± 0.01
SampleContent (mg/g extract)
AmpelopsinTaxifolinMyricetinQuercetin
07030.88 ± 0.050.86 ± 0.050.17 ± 0.010.13 ± 0.01
07011.19 ± 0.030.15 ± 0.010.24 ± 0.010.03 ± 0.00
0807-51.17 ± 0.030.93 ± 0.020.06 ± 0.010.04 ± 0.01
0807-60.33 ± 0.071.64 ± 0.010.04 ± 0.010.05 ± 0.01

Discussion

In this study, we developed a simultaneous quantitation method for major bioactive flavonoids of HFE, ampelopsin, taxifolin, myricetin and quercetin, using HPLC. The developed method was validated in terms of specificity, linearity, accuracy, precision and recovery, and all validation parameters measured were satisfactory for the quantitation of the constituents from HFE. The LOD and LOQ values for each analyte were low enough to determine the content of these flavonoids from HFE samples and also comparable or improved to those reported in the previously published articles (2831).

According to the reports published regarding chemical composition and biological activities of H. dulcis fruits, various polyphenolic compounds and triterpene saponins have been reported as biologically active compounds of H. dulcis fruits (8, 9, 1417). However, the content of those constituents, chemical profile or chromatographic data of H. dulcis fruit extracts has not yet been reported. Thus, the information on the principal components of H. dulcis fruits, in terms of their content and biological contribution to the beneficial effects of H. dulcis fruits, has not been available. In this context, chromatographic studies may provide such information to elucidate the underlying mechanism of functional foods, as well as to establish the marker compounds for quality assessment. To our knowledge, this is the first study to report the chromatographic profile, validated QC method and flavonoids content of H. dulcis fruit extracts.

Conclusion

In this study, an HPLC method for the simultaneous quantitation of the four major flavonoids (ampelopsin, taxifolin, myricetin and quercetin) found in HFE samples was developed and validated. Validation results showed this method to be sensitive, accurate and reproducible. The developed method was successfully applied to determine the flavonoid content of different batches of HFE samples. Therefore, the present method could be utilized for quality assessment of dietary supplements and functional food products containing HFE.

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry (NRF-2014R1A1A1A05002840).

References

1

Lim
T.
;
Hovenia dulcis. Edible medicinal and non-medicinal plants
.
Springer
,
Netherlands
, (
2013
), pp.
568
577
.

2

Chen
S.
,
Zhong
G.
,
Li
A.
,
Li
S.
,
Wu
L.
;
Influence of Hovenia dulcis on alcohol concentration in blood and activity of alcohol dehydrogenase (ADH) of animals after drinking
;
Zhongguo Zhong Yao Za Zhi
, (
2006
);
31
(13)
:
1094
1096
.

3

Hyun
T.K.
,
Eom
S.H.
,
Yu
C.Y.
,
Roitsch
T.
;
Hovenia dulcis—an Asian traditional herb
;
Planta Medica
, (
2010
);
76
(10)
:
943
949
.

4

Wang
M.
,
Zhu
P.
,
Jiang
C.
,
Ma
L.
,
Zhang
Z.
,
Zeng
X.
;
Preliminary characterization, antioxidant activity in vitro and hepatoprotective effect on acute alcohol-induced liver injury in mice of polysaccharides from the peduncles of Hovenia dulcis
;
Food and Chemical Toxicology
, (
2012
);
50
(9)
:
2964
2970
.

5

Na
C.-S.
,
Yoon
S.Y.
,
Kim
J.B.
,
Na
D.S.
,
Dong
M.S.
,
Lee
M.Y.
et al. .;
Anti-fatigue activity of Hovenia dulcis on a swimming mouse model through the inhibition of stress hormone expression and antioxidation
;
The American Journal of Chinese Medicine
, (
2013
);
41
(04)
:
945
955
.

6

Ji
Y.
,
Chen
S.
,
Zhang
K.
,
Wang
W.
;
Effects of Hovenia dulcis Thunb on blood sugar and hepatic glycogen in diabetic mice
;
Zhong Yao Cai
, (
2002
);
25
(3)
:
190
191
.

7

Kim
H.-L.
,
Sim
J.-E.
,
Choi
H.-M.
,
Choi
I.Y.
,
Jeong
M.Y.
,
Park
J.
et al. .;
The AMPK pathway mediates an anti-adipogenic effect of fruits of Hovenia dulcis Thunb
;
Food & Function
, (
2014
);
5
(11)
:
2961
2968
.

8

Yoshikawa
M.
,
Murakami
T.
,
Ueda
T.
,
Matsuda
H.
,
Yamahara
J.
,
Murakami
N.
;
Bioactive saponins and glycosides. IV. Four methyl-migrated 16,17-seco-dammarane triterpene gylcosides from Chinese natural medicine, hoveniae semen seu fructus, the seeds and fruit of Hovenia dulcis THUNB.: absolute stereostructures and inhibitory activity on histamine release of hovenidulciosides A1, A2, B1, and B2
;
Chemical & Pharmaceutical Bulletin
, (
1996
);
44
(9)
:
1736
1743
.

9

Yoshikawa
M.
,
Ueda
T.
,
Muraoka
O.
,
Aoyama
H.
,
Matsuda
H.
,
Shimoda
H.
et al. .;
Absolute stereostructures of hovenidulciosides A1 and A2, bioactive novel triterpene glycosides from hoveniae semen seu fructus, the seeds and fruit of Hovenia dulcis Thunb
;
Chemical & Pharmaceutical Bulletin
, (
1995
);
43
(3)
:
532
534
.

10

Castro
T.C.D.
,
Pelliccione
V.L.B.
,
Figueiredo
M.R.
,
Soares
R.O.D.A.
,
Bozza
M.T.
,
Viana
V.R.C.
et al. .;
Atividade antineoplásica e tripanocida de Hovenia dulcis Thunb. cultivada in vivo e in vitro
;
Revista Brasileira de Farmacognosia
, (
2002
);
12
:
96
99
.

11

Xiang
J.
,
Zhu
W.
,
Li
Z.
,
Ling
S.
;
Effect of juice and fermented vinegar from Hovenia dulcis peduncles on chronically alcohol-induced liver damage in mice
;
Food & Function
, (
2012
);
3
(6)
:
628
634
.

12

Park
E.
,
Ye
E.
,
Kim
S.
,
Choi
H.
,
Bae
M.
;
Eliminatory effect of health drink containing Hovenia dulcis Thunb extract on ethanol-induced hangover in rats
;
Journal of The Korean Society of Dietary Culture
, (
2006
);
21
:
71
75
.

13

Jung
S.-Y.
,
Lim
J.-S.
,
Song
H.-S.
;
Alcohol dehydrogenase activity and sensory evaluation of hutgae (Hovenia dulcis Thunb) fruit soy sauce
;
The Korean Journal of Food and Nutrition
, (
2012
);
25
(4)
:
747
754
.

14

Yoshikawa
M.
,
Murakami
T.
,
Ueda
T.
,
Yoshizumi
S.
,
Ninomiya
K.
,
Murakami
N.
et al. .;
Bioactive constituents of Chinese natural medicines. III. Absolute stereostructures of new dihydroflavonols, hovenitins I, II, and III, isolated from hoveniae semen seu fructus, the seed and fruit of Hovenia dulcis THUNB.(Rhamnaceae): inhibitory effect on alcohol-induced muscular relaxation and hepatoprotective activity
;
Yakugaku Zasshi
, (
1997
);
117
(2)
:
108
118
.

15

Ding
L.
,
Liang
Q.
,
Teng
Y.
;
Study on flavonoids in seeds of Hovenia dulcis
;
Yao Xue Xue Bao
, (
1997
);
32
(8)
:
600
602
.

16

Xu
B.J.
,
Lee
J.H.
,
Sung
C.K.
;
Review: chemical compositions of the genus Hovenia
;
Natural Product Sciences
, (
2003
);
9
(3)
:
143
153
.

17

ShuZhen
Y.
,
QiuSheng
F.
;
The nootropic components of Hovenia dulcis
;
Academic Journal of Second Military Medical University
, (
2009
);
30
(11)
:
1281
1287
.

18

Cha
P.-H.
,
Shin
W.
,
Zahoor
M.
,
Kim
H.-Y.
,
Choi
K.-Y.
;
Hovenia dulcis Thunb extract and its ingredient methyl vanillate activate Wnt/β-catenin pathway and increase bone mass in growing or ovariectomized mice
;
PLoS One
, (
2014
);
9
(1)
:
e85546
.

19

Hase
K.
,
Ohsugi
M.
,
Xiong
Q.
,
Basnet
P.
,
Kadota
S.
,
Namba
T.
;
Hepatoprotective effect of Hovenia dulcis THUNB. on experimental liver injuries induced by carbon tetrachloride or d-galactosamine/lipopolysaccharide
;
Biological & Pharmaceutical Bulletin
, (
1997
);
20
(4)
:
381
385
.

20

Yoo
S.M.
,
Mun
S.
,
Kim
J.-H.
;
Recovery and pre-purification of (+)-dihydromyricetin from Hovenia dulcis
;
Process Biochemistry
, (
2006
);
41
(3)
:
567
570
.

21

Shen
Y.
,
Lindemeyer
A.K.
,
Gonzalez
C.
,
Shao
X.M.
,
Spigelman
I.
,
Olsen
R.W.
et al. .;
Dihydromyricetin as a novel anti-alcohol intoxication medication
;
The Journal of Neuroscience
, (
2012
);
32
(1)
:
390
401
.

22

Lee
S.B.
,
Cha
K.H.
,
Selenge
D.
,
Solongo
A.
,
Nho
C.W.
;
The chemopreventive effect of taxifolin is exerted through ARE-dependent gene regulation
;
Biological and Pharmaceutical Bulletin
, (
2007
);
30
(6)
:
1074
1079
.

23

Duthie
S.
,
Collins
A.
,
Duthie
G.
,
Dobson
V.
;
Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes
;
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
, (
1997
);
393
(3)
:
223
231
.

24

Ong
K.C.
,
Khoo
H.-E.
;
Effects of myricetin on glycemia and glycogen metabolism in diabetic rats
;
Life Sciences
, (
2000
);
67
(14)
:
1695
1705
.

25

Medeiros
K.
,
Figueiredo
C.
,
Figueredo
T.
,
Freire
K.R.I.
,
Santos
F.A.R.
,
Alcantara-Neves
N.M.
et al. .;
Anti-allergic effect of bee pollen phenolic extract and myricetin in ovalbumin-sensitized mice
;
Journal of Ethnopharmacology
, (
2008
);
119
(1)
:
41
46
.

26

Xavier
C.P.
,
Lima
C.F.
,
Rohde
M.
,
Pereira-Wilson
C.
;
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation
;
Cancer Chemotherapy and Pharmacology
, (
2011
);
68
(6)
:
1449
1457
.

27

Jung
C.H.
,
Cho
I.
,
Ahn
J.
,
Jeon
T.I.
,
Ha
T.Y.
;
Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes
;
Phytotherapy Research
, (
2013
);
27
(1)
:
139
143
.

28

Jin
M.-Y.
,
Ding
Y.
,
Zhang
T.
,
Cai
Z.-Z.
,
Tao
J.-S.
;
Simultaneous determination of dihydromyricetin and resveratrol in Ampelopsis sinica (Miq.) WT Wang by high-performance liquid chromatography coupled with a diode array detection method
;
Journal of Chromatographic Science
, (
2014
);
52
(4)
:
339
343
.

29

Tan
Y.
,
Tong
M.
,
Zhang
Y.
,
Xu
Y.
,
Zhai
Y.
;
Determination of taxifolin in Polygonum orientale of different storage period
;
Zhongguo Zhong Yao Za Zhi
, (
2013
);
38
(17)
:
2779
2781
.

30

Cui-ping
Z.
,
Shuai
H.
,
Wen-ting
W.
,
Shun
P.
,
Xiao-ge
S.
,
Ya-jing
L.
et al. .;
Development of high-performance liquid chromatographic for quality and authenticity control of Chinese propolis
;
Journal of Food Science
, (
2014
);
79
(7)
:
C1315
C1322
.

31

Li
B.
,
Wang
M.
,
Tan
Y.
,
Tong
M.
,
Zhai
Y.
;
Simultaneous determination of four flavones in root and stem of Cudrania tricuspidata and C. cochinchinensis by HPLC-DAD
;
Zhongguo Zhong Yao Za Zhi, China Journal of Chinese Materia Medica
, (
2013
);
38
(2)
:
167
170
.

32

Biesaga
M.
;
Influence of extraction methods on stability of flavonoids
;
Journal of Chromatography A
, (
2011
);
1218
(18)
:
2505
2512
.

33

Buchner
N.
,
Krumbein
A.
,
Rohn
S.
,
Kroh
L.W.
;
Effect of thermal processing on the flavonols rutin and quercetin
;
Rapid Communications in Mass Spectrometry
, (
2006
);
20
(21)
:
3229
3235
.

34

Obied
H.K.
,
Bedgood
D.R.
Jr
,
Prenzler
P.D.
,
Robards
K.
;
Effect of processing conditions, prestorage treatment, and storage conditions on the phenol content and antioxidant activity of olive mill waste
;
Journal of Agricultural and Food Chemistry
, (
2008
);
56
(11)
:
3925
3932
.